Scott Mendel, Director at Akoya Biosciences, Inc. (AKYA), bought 20,000 shares at $5.00 ($100K) on 2023-06-12, disclosed to the SEC on 2023-06-12.
Open-market purchase of $100k AKYA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| GNMK | SELL | 2021-01-21 | $727K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $110K | — | Filing → |